专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

41. 发明授权

US5544059A Traffic means controlling apparatus 失效
标题翻译：交通意味着控制装置
公开(公告)号：US5544059A
公开(公告)日：1996-08-06
申请号：US277502
申请日：1994-07-19
申请人： Shiro Hikita , Masafumi Iwata , Kiyotoshi Komaya , Masashi Asuka , Yukio Goto
发明人： Shiro Hikita , Masafumi Iwata , Kiyotoshi Komaya , Masashi Asuka , Yukio Goto
IPC分类号： B66B3/00 , B66B1/18 , B66B1/20 , B66B1/24 , B66B5/00 , G08G1/00 , G08G1/01 , G08G1/08 , G08G9/00 , B66B1/00
CPC分类号： B66B1/34 , B66B1/2408 , B66B1/2458 , B66B5/0006 , B66B5/0037 , G08G1/08 , B66B2201/102 , B66B2201/211 , B66B2201/222 , B66B2201/402 , B66B2201/403
摘要： The feature distinguishing part distinguishes feature modes from the traffic volume data detected by the traffic volume detecting part or from the traffic volume data estimated from the detected traffic volume data by the traffic volume estimating part, and the control parameter setting part sets the optimum control parameter according to the distinction results, further the drive controlling part controls the drive of cars on the control parameters. The distinction function constructing part constructs and modifies the distinction function of feature modes by learning prepared plural feature modes or the distinction results of past feature modes, furthermore the control result detecting part detects the control results or the drive results of cars, and corrects the control parameters. The control results or the drive results are exhibited on the user interface, and the control parameters are set and corrected from the outside by referring the results.
摘要翻译：特征区分部分将特征模式与由流量检测部检测到的流量数据或者由业务量估计部从检测到的业务量数据估计的业务量数据进行区分，并且控制参数设定部设定最优控制参数根据区分结果，驱动控制部分进一步控制汽车对控制参数的驱动。区分函数构造部分通过学习准备的多种特征模式或过去特征模式的区别结果来构建和修改特征模式的区别功能，此外，控制结果检测部分检测汽车的控制结果或驱动结果，并且校正控制参数。控制结果或驱动结果显示在用户界面上，并通过参考结果从外部设置和修正控制参数。

42. 发明申请

US20100286085A1 NOVEL CHONDROITIN SULFATE HAVING DECREASED MOLECULAR WEIGHT AND USE THEREOF 审中-公开
标题翻译：具有降解分子量的新型磺酸钠及其用途
公开(公告)号：US20100286085A1
公开(公告)日：2010-11-11
申请号：US12680995
申请日：2008-10-01
申请人： Kazuhiro Kojima , Yukio Goto , Hiroshi Maeda
发明人： Kazuhiro Kojima , Yukio Goto , Hiroshi Maeda
IPC分类号： A61K31/715 , C08B37/08 , A61P7/02
CPC分类号： A61M1/287 , A61K31/726 , A61K31/737 , C08B37/0069 , C08J3/28 , C08J2305/08 , C08K3/02 , C08K3/08 , C08K5/09 , C08L5/08
摘要： An object of the present invention is to provide a chondroitin sulfate having a decreased molecular weight which has utilization as an inhibitor of peritoneal disorder caused by long-term use of a peritoneal dialysis fluid containing glucose or a polysaccharide thereof as an osmotic agent, utilization as an osmotic agent in a peritoneal dialysis fluid, and the like. The chondroitin sulfate having a decreased molecular weight of the present invention as a means for achieving the object is characterized by having a weight average molecular weight of from 1000 to 20000 and containing a constituent disaccharide unit represented by the following structural formula in an amount of from 65 o to 100% (molar ratio) of the total. -[4GlcAβ1-3GalNAc(6S)β1]- (wherein GlcA represents a D-glucuronic acid residue; GalNAc represents an N-acetyl-D-galactosamine residue; β1-3 represents a β1-3 glycosidic linkage; β1-4 represents a β1-4 glycosidic linkage; and (6S) indicates that position 6 of the monosaccharide residue is sulfated)
摘要翻译：本发明的目的是提供一种具有降低的分子量的硫酸软骨素，其具有作为腹膜病的抑制剂的作用，其可以长期使用含有葡萄糖或其多糖的腹膜透析液作为渗透剂，利用为腹膜透析液中的渗透剂等。本发明的分子量降低的硫酸软骨素作为实现目的的手段，其特征在于重均分子量为1000〜20000，含有下列结构式所示的构成的二糖单元，其量为 65〜100％（摩尔比）。 - [4GlcA＆bgr; 1-3GalNAc（6S）＆bgr; 1] - （其中GlcA表示D-葡萄糖醛酸残基; GalNAc表示N-乙酰基-D-半乳糖胺残基;＆lt; bgr; 1-3代表＆糖苷键; 1-4表示1-4糖苷键;（6S）表示单糖残基的6位被硫酸化）

43. 发明申请

US20060205819A1 Methods of treatment inflammatory bowel with lxr agonists 审中-公开
标题翻译：用lxr激动剂治疗炎症性肠道的方法
公开(公告)号：US20060205819A1
公开(公告)日：2006-09-14
申请号：US10566637
申请日：2004-07-27
申请人： Yukio Goto , Hideo Kikkawa , Mine Kinoshita
发明人： Yukio Goto , Hideo Kikkawa , Mine Kinoshita
IPC分类号： A61K31/195 , A61K31/18
CPC分类号： A61K31/195 , A61K31/00 , A61K31/18 , A61K31/196
摘要： The present invention relates generally to the use of LXR agonists in the prevention and/or treatment of inflammatory bowel diseases.
摘要翻译：本发明一般涉及LXR激动剂在预防和/或治疗炎性肠病中的应用。

44. 发明申请

US20050069628A1 Powder composition 审中-公开
标题翻译：粉末组成
公开(公告)号：US20050069628A1
公开(公告)日：2005-03-31
申请号：US10982773
申请日：2004-11-08
申请人： Yukio Goto , Shigeru Tanaka , Hiroshi Ishii
发明人： Yukio Goto , Shigeru Tanaka , Hiroshi Ishii
IPC分类号： A23G3/00 , A23G3/34 , A23G3/42 , A23G4/00 , A23G4/10 , A23L1/00 , A23L1/09 , A23L1/22 , A23L1/222 , A23L1/236 , A23L2/39 , A61K8/02 , A61K8/11 , A61K8/30 , A61K8/34 , A61K8/60 , A61K8/64 , A61K8/67 , A61K8/72 , A61K8/73
CPC分类号： A23G3/346 , A23G3/42 , A23G4/10 , A23G2200/06 , A23L5/00 , A23L27/00 , A23L27/13 , A23L27/33 , A23L29/30 , A23L29/35 , A23P10/30 , A23V2002/00 , A23V2250/636
摘要： The invention encompasses a powder composition with low hygroscopicity, excellent storage stability, easy uniform dispersion of a core substance, a sufficient amount of the core substance, and excellent taste without attachment onto teeth even after addition to chewing gum or tablet confectioneries, which is preferable for use as an agent for giving aroma and flavor or an agent for enhancing aroma and flavor, as well as foods and drinks containing the same. The powder composition is produced by melting a carbohydrate mixture comprising about 30% to 70% by mass of trehalose and a plasticizer under heating, adding a core substance to the resulting molten matter for mixing to obtain a uniform mixture, extruding the uniform mixture while cooling the uniform mixture, for solidification, and cutting or grinding the resulting solid matter. The resulting powder composition is kneaded with for example gum base, powder sugar, corn syrup and the like and is then spread into stick chewing gum.
摘要翻译：本发明包括具有低吸湿性，优异的储存稳定性，核心物质的容易均匀分散，足够量的核心物质以及优异的味道，甚至在添加到口香糖或片糖食之后也不会附着在牙齿上的粉末组合物，这是优选的用作赋予香气和风味的药剂或用于增强香气和风味的药剂，以及含有其的食品和饮料。粉末组合物通过在加热下熔化包含约30〜70质量％的海藻糖和增塑剂的碳水化合物混合物来制备，向所得熔融物质中加入核心物质进行混合以获得均匀的混合物，同时冷却均匀的混合物均匀混合物，用于固化，切割或研磨所得固体物质。将得到的粉末组合物与例如胶基，粉末糖，玉米糖浆等混合，然后扩散到棒状口香糖中。

45. 发明授权

US5158775A Aerosols of pyrido [1,2-a]pyrimidine compounds 失效
标题翻译：吡啶并[1,2-a]嘧啶化合物的气溶胶
公开(公告)号：US5158775A
公开(公告)日：1992-10-27
申请号：US538104
申请日：1990-06-14
申请人： Takashi Yazaki , Yukio Goto
发明人： Takashi Yazaki , Yukio Goto
IPC分类号： A61K9/12 , A61K9/00 , A61K31/505
CPC分类号： A61K9/008 , A61K31/505
摘要： A suspension type aerosol inhalations containing (a) 0.015 to 5.00% (w/w) of a pyrido[1,2-a]pyrimidine compound of the formula: ##STR1## where R is a n-propyl or allyl group, A is a tetrazolyl or carboxyl group, and n is a whole number of 0 to 2, and (b) 0.015 to 5.00% (w/w) of a fatty acid ester.
摘要翻译：含有（a）0.015至5.00％（w / w）下式的吡啶并[1,2-a]嘧啶化合物的悬浮型气溶胶吸入剂，其中R为正丙基或烯丙基，A为四唑基或羧基，n为0〜2的整数，（b）为脂肪酸酯的0.015〜5.00％（w / w）。

46. 发明授权

US4174557A Method of mounting valve seats in a butterfly valve 失效
标题翻译：将阀座安装在蝶阀中的方法
公开(公告)号：US4174557A
公开(公告)日：1979-11-20
申请号：US892341
申请日：1978-03-31
申请人： Yukio Goto , Osamu Nakai , Ikuo Yoshimori
发明人： Yukio Goto , Osamu Nakai , Ikuo Yoshimori
IPC分类号： F16K1/226 , F16K1/42 , B23P15/00
CPC分类号： F16K1/2263 , Y10T29/49409 , Y10T29/49412 , Y10T29/49963
摘要： A method of mounting valve seats in a butterfly valve comprising a valve body mounted in a valve stem in a valve housing. The valve seats are attached to the valve housing so as to contact the periphery of the valve body when the valve is closed. End surfaces of the valve seats are adjusted relative to the valve stem and seal members by means of first bolts. Then, the first bolts are replaced with third bolts for pressing the valve seats against the periphery of the valve body.
摘要翻译：一种将阀座安装在蝶阀中的方法，其包括安装在阀壳中的阀杆中的阀体。阀座连接到阀壳体上，以便当阀门关闭时接触阀体的周边。通过第一螺栓相对于阀杆和密封构件调节阀座的端面。然后，用用于将阀座压靠在阀体周边上的第三螺栓来代替第一螺栓。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式